miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells

References

• Sun X, Liu J, Xu C, Tang SC, Ren H. The insights of Let‐7 miRNAs in oncogenesis and stem cell potency. J Cell Mol Med. 2016;20:1779-88. doi:10.1111/jcmm.12861
   PubMed Web of Science ®Google Scholar
• Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445-64. doi:10.1038/nrclinonc.2015.61
   PubMed Web of Science ®Google Scholar
• Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG. MicroRNAs and cancer stem cells: the sword and the shield. Oncogene. 2014;33:4967-77. doi:10.1038/onc.2013.492
   PubMed Web of Science ®Google Scholar
• Ni T, Li X-Y, Lu N, An T, Liu Z-P, Fu R, Lv W-C, Zhang Y-W, Xu X-J, Grant Rowe R, et al. Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Nat Cell Biol. 2016;18:1221-32. doi:10.1038/ncb3425
   PubMed Web of Science ®Google Scholar
• Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25:254-64. doi:10.1016/j.ceb.2013.01.004
   PubMed Web of Science ®Google Scholar
• Su J, Wu S, Wu H, Li L, Guo T. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling. Mol Carcinog. 2016;55:1962-73. doi:10.1002/mc.22443
   PubMed Web of Science ®Google Scholar
• Stewart DJ. Wnt signaling pathway in non–small cell lung cancer. J Nat Cancer Inst. 2014;106:1-11. doi:10.1093/jnci/djt356
   Google Scholar
• Basu S, Haase G, Ben-Ze'ev A. Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Research. 2016;5:F1000 Faculty Rev-699. doi:10.12688/f1000research.7579.1
   Google Scholar
• Wang J, Zhang B, Meng J, Xiao G, Li X, Li G, Qin S, Du N, Zhang J, Zhang J, et al. Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China. Experimental and Therapeutic Medicine. 2017;14:2584-94.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang L, Fan K, Cheng ZX, Sun QC, Wang JJ. Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the Wnt/beta-Catenin pathway. Biomed Res Int. 2016;2016:1579490. doi:10.1155/2016/1579490
   PubMed Web of Science ®Google Scholar
• Blagodatski A, Poteryaev D, Katanaev VL. Targeting the Wnt pathways for therapies. Mol Cell Ther. 2014;2:28. doi:10.1186/2052-8426-2-28
   PubMedGoogle Scholar
• Mao J, Fan S, Ma W, Fan P, Wang B, Zhang J, Wang H, Tang B, Zhang Q, Yu X, et al. Roles of Wnt/[beta]-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:e1039. doi:10.1038/cddis.2013.515
   PubMed Web of Science ®Google Scholar
• Zhang X, Lou Y, Wang H, Zheng X, Dong Q, Sun J, Han B. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells. Medical Oncology. 2015;32:95. doi:10.1007/s12032-014-0462-1
   PubMed Web of Science ®Google Scholar
• Pang Y, Liu J, Li X, Zhang Y, Zhang B, Zhang J, Du N, Xu C, Liang R, Ren H, et al. Nano Let-7b sensitization of eliminating esophageal cancer stem-like cells is dependent on blockade of Wnt activation of symmetric division. Int J Oncol. 2017;51:1077–88. doi: 10.3892/ijo.2017.4104
   PubMed Web of Science ®Google Scholar
• Li L, Cole J, Margolin DA. Cancer stem cell and stromal microenvironment. Ochsner J. 2013;13:109-18.
   PubMedGoogle Scholar
• Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, et al. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer. Cell Death Dis. 2015;6:e1850. doi:10.1038/cddis.2015.217
   PubMed Web of Science ®Google Scholar
• Zakaria N, Yusoff NM, Zakaria Z, Lim MN, Baharuddin PJN, Fakiruddin KS, Yahaya B. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells. BMC Cancer. 2015;15:84. doi:10.1186/s12885-015-1086-3
   PubMed Web of Science ®Google Scholar
• Koch L. Functional genomics: Screening for lncRNA function. Nat Rev Genet. 2017; 18:70. doi:10.1038/nrg.2016.168
   Web of Science ®Google Scholar
• Schmitt Adam M, Chang Howard Y. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452-63. doi:10.1016/j.ccell.2016.03.010
   PubMed Web of Science ®Google Scholar
• Tsanov K, Pearson D, Wu Z, Han A, Triboulet R, Seligson M, Powers J, Osborne J, Kane S, Gygi S, et al. LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. Nat Cell Biol. 2017;19:60-7.
   PubMed Web of Science ®Google Scholar
• Ye J, Blelloch R. Regulation of pluripotency by RNA binding proteins. Cell Stem Cell. 2014;15:271-80. doi:10.1016/j.stem.2014.08.010
   PubMed Web of Science ®Google Scholar
• Kaid C, Silva PB, Cortez BA, Rodini CO, Semedo-Kuriki P, Okamoto OK. miR-367 promotes proliferation and stem-like traits in medulloblastoma cells. Cancer Sci. 2015;106:1188-95. doi:10.1111/cas.12733
   PubMed Web of Science ®Google Scholar
• Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ohno S, Mori M, Mimori K, Nakayama KI. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest. 2015;125:621-35. doi:10.1172/JCI78782
   PubMed Web of Science ®Google Scholar
• Takeishi S, Nakayama KI. Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells. Br J Cancer. 2014;111:1054-9. doi:10.1038/bjc.2014.259
   PubMed Web of Science ®Google Scholar
• Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S, Paquis P, Preynat-Seauve O, Krause KH, Chneiweiss H, et al. The miR 302–367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ. 2012;19:232-44. doi:10.1038/cdd.2011.89
   PubMed Web of Science ®Google Scholar
• Yang SL, Yang M, Herrlinger S, Liang C, Lai F, Chen JF. MiR-302/367 regulate neural progenitor proliferation, differentiation timing, and survival in neurulation. Dev Biol. 2015;408:140-50. doi:10.1016/j.ydbio.2015.09.020
   PubMed Web of Science ®Google Scholar
• Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J, Wang P. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-beta signalling pathway. Br J Cancer. 2015;112:1367-75. doi:10.1038/bjc.2015.102
   PubMed Web of Science ®Google Scholar
• Nosrati A, Naghshvar F, Khanari S. Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma. Int J Mol Cell Med. 2014;3:279-86.
   PubMedGoogle Scholar
• Huang M, Zhu H, Feng J, Ni S, Huang J. High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer. Dis Markers. 2015;2015:986095. doi:10.1155/2015/986095
   PubMed Web of Science ®Google Scholar
• Liu QF, Zhang ZF, Hou GJ, Yang GY, He Y. Polymorphisms of the stem cell marker gene CD133 and the risk of lung cancer in Chinese population. Lung. 2016;194:393-400. doi:10.1007/s00408-016-9876-1
   PubMed Web of Science ®Google Scholar
• Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, et al. Highly tumorigenic lung cancer CD133(+) cells display stem-like features and are spared by cisplatin treatment. Proc Nat Acad Sci U S A. 2009;106:16281-6. doi:10.1073/pnas.0905653106
   PubMed Web of Science ®Google Scholar
• Wang P, Suo Z, Wang M, Høifødt HK, Fodstad Ø, Gaudernack G, Kvalheim G. In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Exp Hemat Oncol. 2013;2:16-. doi:10.1186/2162-3619-2-16
   PubMedGoogle Scholar
• Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD, Sethi T. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res. 2014;74:1554-65. doi:10.1158/0008-5472.CAN-13-1541
   PubMed Web of Science ®Google Scholar
• Roudi R, Korourian A, Shariftabrizi A, Madjd Z. Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes. Cancer Invest. 2015;33:294-302. doi:10.3109/07357907.2015.1034869
   PubMed Web of Science ®Google Scholar
• Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7:11018-32. doi:10.18632/oncotarget.6920
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. doi:10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401. doi:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 2016;160:439-46. doi:10.1007/s10549-016-4013-7
   PubMed Web of Science ®Google Scholar
• Győrffy B, Bottai G, Lehmann-Che J, Kéri G, Őrfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H, et al. TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers. Mol Oncol. 2014;8:508-19. doi:10.1016/j.molonc.2013.12.018
   PubMed Web of Science ®Google Scholar
• Cimadamore F, Amador-Arjona A, Chen C, Huang C-T, Terskikh AV. SOX2–LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. Proc Nat Acad Sci. 2013;110:E3017-E26. doi:10.1073/pnas.1220176110
   PubMed Web of Science ®Google Scholar
• Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends in Cell Biology. 2012;22:474-82. doi:10.1016/j.tcb.2012.06.001
   PubMed Web of Science ®Google Scholar
• Dror S, Sander L, Schwartz H, Sheinboim D, Barzilai A, Dishon Y, Apcher S, Golan T, Greenberger S, Barshack I, et al. Melanoma miRNA trafficking controls tumour primary niche formation. Nat Cell Biol. 2016;18:1006-17. doi:10.1038/ncb3399
   PubMed Web of Science ®Google Scholar
• Copley MR, Babovic S, Benz C, Knapp DJHF, Beer PA, Kent DG, Wohrer S, Treloar DQ, Day C, Rowe K, et al. The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol. 2013;15:916-25. doi:10.1038/ncb2783
   PubMed Web of Science ®Google Scholar
• Sun X, Xu C, Tang SC, Wang J, Wang H, Wang P, Du N, Qin S, Li G, Xu S, et al. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells. Cancer Gene Ther. 2016;23:83-9. doi:10.1038/cgt.2016.3
   PubMed Web of Science ®Google Scholar
• Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK. Let-7 represses carcinogenesis and a stem cell phenotype in the intestine via regulation of Hmga2. PLoS Genet. 2015;11:e1005408. doi:10.1371/journal.pgen.1005408
   PubMed Web of Science ®Google Scholar
• Zha L, Zhang J, Tang W, Zhang N, He M, Guo Y, Wang Z. HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer. Dig Dis Sci. 2013;58:724-33. doi:10.1007/s10620-012-2399-6
   PubMed Web of Science ®Google Scholar
• Wend P, Runke S, Wend K, Anchondo B, Yesayan M, Jardon M, Hardie N, Loddenkemper C, Ulasov I, Lesniak MS, et al. WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Mol Med. 2013;5:264-79. doi:10.1002/emmm.201201320
   PubMed Web of Science ®Google Scholar
• Shyh-Chang N, Daley George Q. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell.2013;12:395-406.
   PubMed Web of Science ®Google Scholar
• Sun X, Qin S, Fan C, Xu C, Du N, Ren H. Let-7: a regulator of the ERalpha signaling pathway in human breast tumors and breast cancer stem cells. Oncol Rep. 2013;29:2079-87. doi:10.3892/or.2013.2330
   PubMed Web of Science ®Google Scholar